HBsAg
Spezies: Hepatitis B Virus (HBV), Human
Wirt: Human
Native
ELISA
Active
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
PBS, pH 7.0 with 0.1 % NaN3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Pereira, Yalçın, Cretich, Chiari, Unlü, Nunes, Bergstein: "Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array." in: Journal of immunological methods, Vol. 371, Issue 1-2, pp. 159-64, (2011) (PubMed).
Target
HBSAg (HBsAg)
(Hepatitis B Virus Surface Antigen (HBsAg))
Hepatitis B is an infectious illness caused by hepatitis B virus (HBV) which infects the liver of hominoidea, including humans, and causes an inflammation called hepatitis. The hepatitis B surface antigen (HBsAg) is most frequently used to screen for the presence of this infection. It is the first detectable viral antigen to appear during infection. However, early in an infection, this antigen may not be present and it may be undetectable later in the infection as it is being cleared by the host. Description: Human plasma. Alternative Names: Hepatitis B Surface Ag Subtype ad protein, Hepatitis B surface Ag protein, Hepatitis B Surface Antigen protein